Oct 30, 2026 · 40 min
Personalized risk reshapes breast cancer screening and survivorship
Dense Breasts, Family History and Your Mammogram: How to Know your Real Risk
Family history, genetic findings, breast density, and treatment effects can change both screening decisions and long-term care.
- 1Risk assessment should combine family history, genetic testing, breast density, and validated models rather than rely on one factor.
- 2Risk-reducing surgery and cancer treatment can trigger premature menopause, bone loss, cardiovascular risks, cognitive symptoms, and mental-health challenges.
- 3A negative genetic test does not erase residual family risk, making individualized counseling and coordinated survivorship care essential.
Don't miss
Teplinsky explains why a negative genetic test may not reduce a person with a strong family history to average risk.
The brief
Breast oncologist Eleonora Teplinsky explains how family history, inherited mutations, breast density, and risk models work together to shape screening decisions.
The conversation challenges the promise of direct-to-consumer scans and blood tests, emphasizing that emerging tools should not replace established screening without evidence of clinical value.
Teplinsky details how risk-reducing surgery and cancer treatment can affect menopause, bones, the heart, cognition, mental health, and body image long after treatment ends.
A central warning is that a negative genetic test does not necessarily return someone with a strong family history to average risk.
The episode closes with a practical case for individualized conversations, prepared questions, and coordinated oncology-gynecology survivorship care.
Books & mentions
Some links are affiliate links — PodLume may earn a commission if you buy.
Weekly email
State of the Pod, every Monday
The week's most-discussed names and stories from podcasts, with the moments behind them. Free, five minutes, unsubscribe in one click.